{
  "id": "64137616201352f04a000041",
  "type": "yesno",
  "question": "Anemia is not associated with chronic kidney failure",
  "ideal_answer": "No, anemia is a common complication of chronic kidney failure.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/2010480",
    "http://www.ncbi.nlm.nih.gov/pubmed/35774427",
    "http://www.ncbi.nlm.nih.gov/pubmed/15467179",
    "http://www.ncbi.nlm.nih.gov/pubmed/22680636",
    "http://www.ncbi.nlm.nih.gov/pubmed/29151105",
    "http://www.ncbi.nlm.nih.gov/pubmed/22536082",
    "http://www.ncbi.nlm.nih.gov/pubmed/9241712",
    "http://www.ncbi.nlm.nih.gov/pubmed/16623112",
    "http://www.ncbi.nlm.nih.gov/pubmed/2357306",
    "http://www.ncbi.nlm.nih.gov/pubmed/17437743",
    "http://www.ncbi.nlm.nih.gov/pubmed/31994917",
    "http://www.ncbi.nlm.nih.gov/pubmed/18670732",
    "http://www.ncbi.nlm.nih.gov/pubmed/7034633",
    "http://www.ncbi.nlm.nih.gov/pubmed/16442920",
    "http://www.ncbi.nlm.nih.gov/pubmed/21877597",
    "http://www.ncbi.nlm.nih.gov/pubmed/19833421",
    "http://www.ncbi.nlm.nih.gov/pubmed/22454095",
    "http://www.ncbi.nlm.nih.gov/pubmed/26948278",
    "http://www.ncbi.nlm.nih.gov/pubmed/17108343",
    "http://www.ncbi.nlm.nih.gov/pubmed/32899941",
    "http://www.ncbi.nlm.nih.gov/pubmed/20443766",
    "http://www.ncbi.nlm.nih.gov/pubmed/12076240",
    "http://www.ncbi.nlm.nih.gov/pubmed/9375826"
  ],
  "snippets": [
    {
      "text": "This study was to explore the clinical efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection (recombinant human erythropoietin injection, rHuEPO) for the treatment of anemia associated with chronic kidney failure",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35774427",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anaemia is a common manifestation ofa chronic kidney failure. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21877597",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The hormone deficiency that underlies anemia in chronic kidney failure can now be corrected",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2010480",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We call this interrelationship between congestive heart failure, chronic kidney insufficiency, and anemia the Cardio-Renal Anemia syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15467179",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anemia is a major problem in patients with chronic kidney insufficiency.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15467179",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Correction of the anemia with erythropoietin and intravenous iron led to a marked improvement in patients' functional status and their cardiac function, and to a marked fall in the need for hospitalization and for high-dose diuretics; renal function usually improved or at least stabilized.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15467179",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The anemia is very often associated with chronic kidney disease (CKD).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18670732",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The role of anemia in congestive heart failure and chronic kidney insufficiency: the cardio renal anemia syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15467179",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "While iron deficiency is often stated as a cause of anemia in chronic renal failure prior to end-stage renal disease, its relative contribution is debated.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9375826",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anemia in chronic renal failure is predominantly caused by diminished erythropoietin synthesis by diseased kidneys.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9375826",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We infer that impaired utilization of iron may be a significant factor in the anemia of chronic renal failure.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9375826",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Kidney failure causes anemia and is associated with a very high risk of coronary heart di",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16442920",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Kidney failure is known to cause anemia, which is associated with a higher risk of cardiac failure an",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12076240",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18670732",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "BACKGROUND: Anemia, a common complication of chronic kidney disease, usually develops as a consequence of erythropoietin",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17108343",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In patients with CKD, anemia is often caused by decreased erythropoietin production relative to hemoglobin levels.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22536082",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Clearly more work is needed to clarify the relationship between anemia, CKD and CHF.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18670732",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Use of EPOGEN for treatment of anemia associated with chronic renal failure.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2357306",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " Heart failure, anemia and chronic renal failure are mutually related.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16623112",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32899941",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " Partial, but not complete, correction of anemia is associated with improved outcomes in patients with CKD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19833421",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " The high prevalence of anemia in chronic kidney disease is explained by a combination of erythropoietin and iron deficiency.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22454095",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Many advanced chronic kidney disease patients have both anemia and chronic heart failure.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22680636",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " In conclusion, anemia is associated with a rapid decrease in kidney function in patients with heart failure, particularly in those with underlying CKD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17437743",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " This analysis was conducted to evaluate whether anemia is a risk factor for kidney function decrease in patients with heart failure.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17437743",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anemia as a risk factor for kidney function decline in individuals with heart failure.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17437743",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "End stage renal disease (ESRD) invariably leads to anemia which has been mainly attributed to compromised release of erythropoietin from the defective kidneys with subsequent impairment of erythropoiesis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29151105",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Chronic kidney disease (CKD) is a widespread health problem in the world and anaemia of renal origin is a common problem.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20443766",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anemia is the most common hematologic complication in end-stage renal disease (ESRD). It is ascribed to decreased erythropoietin production, shortened red blood cell (RBC) lifespan, and inflammation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26948278",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anemia is one of the most characteristic and visable manifestations of chronic renal failure. Investigators in the past decade have provided a better understanding of this anemia. The etiology of the anemia of chronic renal failure has three facets: first is reduced erythropoietin production by damaged kidneys; second is the presence of inhibitors to red blood cell (RBC) production in uremic serum; and third is red blood cell hemolysis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/7034633",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Cardiovascular disease remains the major cause of mortality in patients with end stage renal disease (ESRD). The pathophysiology of cardiac dysfunction in ESRD is complex and not fully understood. However, it appears that the two major determinants of left ventricular (LV) hypertrophy and dysfunction are anemia and hypertension, both of which are very common in ESRD patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9241712",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "NGAL, also known as lipocalin 2, is a stress protein located on the cell surface that is known for its involvement in iron transport. This study is aimed to evaluate the correlation between the iron profile and NGAL concentration in serum among chronic kidney disease patients under dialysis in order to find its diagnostic value with regards to iron deficiency anaemia (IDA).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31994917",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}